160 related articles for article (PubMed ID: 8603883)
1. A step closer to reality: professional flexible labeling for animal drugs.
Gloyd JS
J Am Vet Med Assoc; 1996 Feb; 208(4):457-9. PubMed ID: 8603883
[No Abstract] [Full Text] [Related]
2. Review of the first interactive workshop on professional flexible labeling. An Animal Health Institute perspective.
Farho CJ
J Am Vet Med Assoc; 1995 Oct; 207(7):869-71. PubMed ID: 7559007
[No Abstract] [Full Text] [Related]
3. Flexible labeling, streamlined drug approval advocated at workshop.
Raef TA
J Am Vet Med Assoc; 1995 Jul; 207(1):7-9. PubMed ID: 7601697
[No Abstract] [Full Text] [Related]
4. Professional drug labeling.
Terry M
J Am Vet Med Assoc; 1993 May; 202(10):1711-2;discussion 1713-7. PubMed ID: 8514591
[No Abstract] [Full Text] [Related]
5. Extralabel drug use and compounding in veterinary medicine.
Geyer RE
Food Drug Law J; 1997; 52(3):291-5. PubMed ID: 10343027
[No Abstract] [Full Text] [Related]
6. Extra-label rules: the final outcome.
Curry-Galvin E
J Am Vet Med Assoc; 1997 Jan; 210(1):10-2. PubMed ID: 8977639
[No Abstract] [Full Text] [Related]
7. Review of the first interactive workshop on professional flexible labeling. The Center for Veterinary Medicine perspective.
Sundlof SF
J Am Vet Med Assoc; 1995 Oct; 207(7):867-8. PubMed ID: 7559006
[No Abstract] [Full Text] [Related]
8. Current FDA policy on use of human-labeled drugs in animals.
Teske RH
J Am Vet Med Assoc; 1993 May; 202(10):1632-3;discussion 1634. PubMed ID: 8514570
[No Abstract] [Full Text] [Related]
9. Implications for the FDA/Center for Veterinary Medicine (CVM).
Geyer RE
J Am Vet Med Assoc; 1993 May; 202(10):1718-23. PubMed ID: 8514592
[No Abstract] [Full Text] [Related]
10. Extra-label drug use--pharmaceutical industry view.
Welser JR
J Am Vet Med Assoc; 1993 May; 202(10):1635-42;discussion 1654-8. PubMed ID: 8514571
[No Abstract] [Full Text] [Related]
11. Scientific basis for nonapproved use of drugs in veterinary practice.
Brumbaugh GW
J Am Vet Med Assoc; 1993 May; 202(10):1693-6;discussion 1713-7. PubMed ID: 8514586
[No Abstract] [Full Text] [Related]
12. AVMA legislation: partial solution to drug availability problem.
Gloyd JS
J Am Vet Med Assoc; 1993 Apr; 202(7):1055-6. PubMed ID: 8473213
[No Abstract] [Full Text] [Related]
13. Compounding forum: FDA-CVM hears veterinarians' views.
J Am Vet Med Assoc; 1993 Nov; 203(10):1367-72. PubMed ID: 8276690
[No Abstract] [Full Text] [Related]
14. Response to comments on the proposed model of a professional drug label.
Martinez MN; Brown SA; Copeland DD; Haibel GK; Koritz GD; Riddell MG; Riviere JE; Rollins LD
J Am Vet Med Assoc; 1996 Dec; 209(12):2068-70. PubMed ID: 8960188
[No Abstract] [Full Text] [Related]
15. Concerned about unlicensed practice.
Allen JM
J Am Vet Med Assoc; 1991 Sep; 199(6):679. PubMed ID: 1955352
[No Abstract] [Full Text] [Related]
16. An overview of current programs on drug development and regulation for small ruminants--pharmaceutical industry perspective.
Terry M
Vet Hum Toxicol; 1993; 35 Suppl 2():12-3. PubMed ID: 8236759
[No Abstract] [Full Text] [Related]
17. Special pesticide formulations. Veterinarians must follow EPA rules.
J Am Vet Med Assoc; 2004 Aug; 225(4):490-1. PubMed ID: 15344349
[No Abstract] [Full Text] [Related]
18. Helpful tips for extralabel drug use: record keeping, record access, and product labels. The FDA-Center for Veterinary Medicine and the American Veterinary Medicine Association.
J Am Vet Med Assoc; 1998 Mar; 212(5):666-7. PubMed ID: 9556375
[No Abstract] [Full Text] [Related]
19. Thoughts on the Schuyler and Algon bulk-drug issue.
Stribling J
J Am Vet Med Assoc; 1988 Oct; 193(8):918-9. PubMed ID: 3192471
[No Abstract] [Full Text] [Related]
20. AVMA guidelines on compounding.
Upson D
J Am Vet Med Assoc; 1994 Jul; 205(2):199-200. PubMed ID: 7928573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
